Jump to content

EGFR & ALK treatment with TECENTRIQ


Recommended Posts


A survival advantage for the TECENTRIQ and Avastin combination regimen was observed in all pre-specified exploratory patient subgroups analyzed, including people with EGFR and ALK mutations, liver metastases and those with varying levels of PD-L1 expression https://www.gene.com/media/press-releases/14722/2018-05-16/phase-iii-impower150-study-showed-genent



Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.